Shanghai Bao Pharma says FDA clears IND for KJ015 anti-HER2 bispecific antibody injectionPUBT·2 days ago, 05:01 AM02659-0.06%
Shanghai Bao Pharmaceuticals schedules board meeting to review interim resultsPUBT·Aug 18 at 03:32 AM02659-0.06%
The Limits of Capital Aggregation: Structural Discounts in the Uncategorized Tail of Hong Kong StocksGlobal Report·Aug 13 at 04:44 AM019780.00%06938+5.12%
The Hong Kong Unbundling: Value Chains and the Niche Supplier OpportunityGlobal Report·Aug 6 at 04:15 AM01187+1.06%02522+9.53%
Shanghai Bao Pharmaceuticals files HKEX next-day disclosure return reporting share repurchasePUBT·Jul 28 at 04:47 AM02659-0.06%
Shanghai Bao Pharma files HKEX next-day return disclosing share repurchase at HKD 17.31 eachPUBT·Jul 24 at 04:44 AM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share repurchase for cancellationPUBT·Jul 22 at 04:45 AM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX next-day disclosure on share repurchasePUBT·Jul 20 at 05:35 AM02659-0.06%
Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6bSimplywall·Jul 17 at 08:00 PM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share buyback at HKD 17.71 eachPUBT·Jul 17 at 05:06 AM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 19.88 average pricePUBT·Jul 15 at 04:58 AM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX disclosure return on share repurchasePUBT·Jul 13 at 05:22 AM02659-0.06%
Shanghai Bao Pharmaceuticals files HKEX next-day return disclosing share repurchase at HKD 19.98 eachPUBT·Jul 10 at 05:02 AM02659-0.06%
Shanghai Bao Pharma files HKEX return disclosing share buyback at HKD 19.53 per sharePUBT·Jul 9 at 05:38 AM02659-0.06%
Shanghai Bao Pharma appoints Tsang Chun Ho as joint company secretary, authorized representative and process agentPUBT·Jul 8 at 04:50 AM02659-0.06%
